Array Technologies, Inc. Reports Financial Results for the Third Quarter 2022 – Delivers record revenue of $515 million and the fourth consecutive quarter of gross margin improvement
Go back to Array Technologies, Inc. Reports Financial Results for the Third Quarter 2022 – Delivers record revenue of $515 million and the fourth consecutive quarter of gross margin improvement| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 7.69 -0.21 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.90 | 52 Week High | $7.27 | |||
| Open | $8.02 | 52 Week Low | $2.39 | |||
| Day High | $8.15 | P/E | N/A | |||
| Day Low | $7.67 | EPS | $-0.61 | |||
| Volume | 4,386,946 | |||||
